Cargando…

Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study

Detalles Bibliográficos
Autores principales: Dellinger, Ryan W., Santos, Santiago Roel, Morris, Mark, Evans, Mal, Alminana, Dan, Guarente, Leonard, Marcotulli, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102308/
https://www.ncbi.nlm.nih.gov/pubmed/30155270
http://dx.doi.org/10.1038/s41514-018-0027-1
_version_ 1783349133080264704
author Dellinger, Ryan W.
Santos, Santiago Roel
Morris, Mark
Evans, Mal
Alminana, Dan
Guarente, Leonard
Marcotulli, Eric
author_facet Dellinger, Ryan W.
Santos, Santiago Roel
Morris, Mark
Evans, Mal
Alminana, Dan
Guarente, Leonard
Marcotulli, Eric
author_sort Dellinger, Ryan W.
collection PubMed
description
format Online
Article
Text
id pubmed-6102308
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61023082018-08-28 Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study Dellinger, Ryan W. Santos, Santiago Roel Morris, Mark Evans, Mal Alminana, Dan Guarente, Leonard Marcotulli, Eric NPJ Aging Mech Dis Author Correction Nature Publishing Group UK 2018-08-20 /pmc/articles/PMC6102308/ /pubmed/30155270 http://dx.doi.org/10.1038/s41514-018-0027-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Author Correction
Dellinger, Ryan W.
Santos, Santiago Roel
Morris, Mark
Evans, Mal
Alminana, Dan
Guarente, Leonard
Marcotulli, Eric
Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
title Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
title_full Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
title_fullStr Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
title_full_unstemmed Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
title_short Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
title_sort author correction: repeat dose nrpt (nicotinamide riboside and pterostilbene) increases nad(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102308/
https://www.ncbi.nlm.nih.gov/pubmed/30155270
http://dx.doi.org/10.1038/s41514-018-0027-1
work_keys_str_mv AT dellingerryanw authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy
AT santossantiagoroel authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy
AT morrismark authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy
AT evansmal authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy
AT alminanadan authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy
AT guarenteleonard authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy
AT marcotullieric authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy